グルコース監視システムの北米市場

Inkwood Researchが発行した調査報告書(INKW709072)
◆英語タイトル:North America Glucose Monitoring System (Cgms & Smbg) Market Forecast 2017-2025
◆商品コード:INKW709072
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2017年8月16日
◆ページ数:87
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGS The growth of the CGMS market in North America region is likely to reach $9372.07 million by 2025. Throughout the forecast period, the expected CAGR is 34.05%. The SMBG North America market is growing with the expected CAGR of 4.64% with the market share of $10178 million in 2016. With an awareness of benefits of using continuous glucose monitoring systems, better healthcare infrastructure accelerated incidences of diabetes due to a sedentary lifestyle and high healthcare expenditure are leading factors for the growth of the GMS market in the region.
MARKET INSIGHTS
The GMS market is segmented into CGMS market and SMBG market, which is further bifurcated into component type, and application. The SMBG market by component type is segmented into the glucose meter, test strips, and others. The market of CGMS by component type is divided into transmitters and receivers, sensors and insulin pump. The application market of SMBG includes clinics, hospitals, and home settings. On the other hand, the market of CGMS application is divided into hospitals, diagnostics and clinics and home settings. Restriction in the growth of CGMS due to SMBG producers and lack of awareness is majorly declining the growth of the GMS market in the North America region.
COMPETITIVE INSIGHTS
The major companies that are mentioned in GMS market report are Medtronic Inc., Ypsomed AG, Novo Nordisk, Bayer AG Roche, Animas Corporation, Glysens Inc., Abbott Laboratories, Insulet Corporation, and Dexcom Inc.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET
1.3. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.2. BOTTOM-UP APPROACH
2.3. TOP DOWN APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY & KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS AND IMPACT
4.1.1. INCREASE IN DIABETIC POPULATION
4.1.2. INCREASE IN HEALTHCARE EXPENDITURE
4.1.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
4.1.4. TECHNOLOGY INTEGRATION
4.1.5. INCREASING CGMS AFFORDABILITY
4.1.6. LOW PRICE OF TECHNOLOGY
4.2. RESTRAIN AND IMPACT
4.2.1. HINDERANCE FROM GOVERNMENT REGULATIONS
4.2.2. SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
4.2.3. INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
4.2.4. LACK OF KNOWLEDGE
4.3. KEY TRENDS
4.3.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
4.3.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
4.3.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
4.3.4. INCREASE IN NON-INVASIVE DEVICES
4.3.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
5. CGMS MARKET BY COMPONENT TYPE
5.1. SENSORS
5.2. TRANSMITTERS AND RECEIVERS
5.3. INSULIN PUMP
6. CGMS MARKET BY APPLICATION
6.1. HOME SETTINGS
6.2. DIAGNOSTICS AND CLINICS
6.3. HOSPITALS
7. SMBG MARKET
8. SMBG MARKET BY COMPONENT TYPE
8.1. TEST STRIPS
8.2. GLUCOSE METER
8.3. OTHERS
9. SMBG MARKET BY APPLICATION
9.1. HOME SETTINGS
9.2. CLINICS
9.3. HOSPITALS
10. KEY ANALYTICAL
10.1. 5 FORCES ANALYSIS
10.1.1. THREAT OF NEW ENTRANT
10.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
10.1.3. BARGAINING POWER OF BUYERS
10.1.4. BARGAINING POWER OF SUPPLIER
10.1.5. INTENSITY OF COMPETITIVE RIVALRY
10.2. MERGER AND ACQUISITION
11. REGIONAL ANALYSIS
11.1. NORTH AMERICA
11.1.1. THE US
11.1.2. CANADA
12. COMPETITIVE LANDSCAPE
12.1. INTRODUCTION
12.2. MEDTRONIC
12.2.1. BUSINESS PROFILE
12.2.2. PRODUCT PORTFOLIO
12.2.3. REVENUE ANALYSIS
12.2.4. STRATEGIC INPUTS
12.2.5. SCOT ANALYSIS
12.3. DEXCOM
12.3.1. BUSINESS PROFILE
12.3.2. PRODUCT PORTFOLIO
12.3.3. REVENUE ANALYSIS
12.3.4. STRATEGIC INPUTS
12.3.5. SCOT ANALYSIS
12.4. ABBOTT
12.4.1. BUSINESS PROFILE
12.4.2. PRODUCT PORTFOLIO
12.4.3. REVENUE ANALYSIS
12.4.4. STRATEGIC INPUTS
12.4.5. SCOT ANALYSIS
12.5. JOHNSON AND JOHNSON
12.5.1. BUSINESS PROFILE
12.5.2. PRODUCT PORTFOLIO
12.5.3. REVENUE ANALYSIS
12.5.4. STRATEGIC INPUTS
12.5.5. SCOT ANALYSIS
12.6. INSULET CORP
12.6.1. BUSINESS PROFILE
12.6.2. PRODUCT PORTFOLIO
12.6.3. REVENUE ANALYSIS
12.6.4. STRATEGIC INPUTS
12.6.5. SCOT ANALYSIS
12.7. TANDEM DIABETES CARE
12.7.1. BUSINESS PROFILE
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. STRATEGIES INPUTS
12.7.5. SCOT ANALYSIS
12.8. ECHO THERAPEUTICS INC
12.8.1. BUSINESS PROFILE
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. STRATEGIES INPUTS
12.8.5. SCOT ANALYSIS
12.9. ROCHE DIAGNOSTICS
12.9.1. BUSINESS PROFILE
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. STRATEGIES INPUTS
12.9.5. SCOT ANALYSIS
12.10. NEMAURA MEDICAL INC
12.10.1. BUSINESS PROFILE
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. STRATEGIES INPUTS
12.10.5. SCOT ANALYSIS
12.11. SENSEONICS INC
12.11.1. BUSINESS PROFILE
12.11.2. REVENUE ANALYSIS
12.11.3. PRODUCT PORTFOLIO
12.11.4. STRATEGIES INPUTS
12.11.5. SCOT ANALYSIS
12.12. GLYSENS INC
12.12.1. BUSINESS PROFILE
12.12.2. STRATEGIES INPUTS
12.12.3. PRODUCT PORTFOLIO
12.12.4. SCOT ANALYSIS

LIST OF TABLES
TABLE 1 NORTH AMERICA CGMS MARKET 2017-2025(IN US$ MILLION)
TABLE 2 NORTH AMERICA SMBG MARKET 2017-2025 (IN US$ MILLION)
TABLE 3 NORTH AMERICA CGMS MARKET, BY COMPONENT TYPE, 2017-2025(IN US$ MILLION)
TABLE 4 NORTH AMERICA CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)
TABLE 5 NORTH AMERICA CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
TABLE 6 NORTH AMERICA CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)
TABLE 7 NORTH AMERICA CGMS MARKET, BY APPLICATION 2017-2025 (IN US$ MILLION)
TABLE 8 NORTH AMERICA CGMS HOME SETTINGS MARKET, 2017-2025(IN US$ MILLION)
TABLE 9 NORTH AMERICA CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)
TABLE 10 NORTH AMERICA CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)
TABLE 11 IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS
TABLE 12 SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICA
TABLE 13 PRODUCT MATRIXES FOR LANCETS
TABLE 14 NORTH AMERICA SMBG MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)
TABLE 15 NORTH AMERICA SMBG MARKET 2017-2025 ($ MILLION)
TABLE 16 NORTH AMERICA CGMS MARKET REVENUE, 2017-2025(IN US$ MILLION)
TABLE 17 NORTH AMERICA SMBG MARKET REVENUE, 2017-2025(IN US$ MILLION)

LIST OF FIGURES
FIGURE 1 NORTH AMERICA CGMS MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 2 NORTH AMERICA CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)
FIGURE 3 NORTH AMERICA CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
FIGURE 4 NORTH AMERICA CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)
FIGURE 5 NORTH AMERICA CGMS MARKET SHARE, BY APPLICATION 2016 & 2025(%)
FIGURE 6 NORTH AMERICA CGMS HOME SETTING MARKET, 2017-2025(IN US$ MILLION)
FIGURE 7 NORTH AMERICA CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)
FIGURE 8 NORTH AMERICA CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)
FIGURE 9 NORTH AMERICA SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(%)
FIGURE 10 NORTH AMERICA SMBG TEST STRIPS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 11 NORTH AMERICA SMBG GLUCOSE METER MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 12 NORTH AMERICA SMBG OTHERS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 13 NORTH AMERICA SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(US$ MILLION)
FIGURE 14 NORTH AMERICA SMBG HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 15 NORTH AMERICA SMBG CLINICAL MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 16 NORTH AMERICA SMBG HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 17 NORTH AMERICA GGMS MARKET SHARE, BY GEOGRAPHY 2016 & 2025(%)
FIGURE 18 NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 19 US CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 20 US SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 21 CANADA CGMS MARKET REVENUE, 2017-2025 (IN USD MILLION)
FIGURE 22 CANADA SMBG MARKET REVENUE, 2017-2025 (IN USD MILLION)



【レポートのキーワード】

グルコース監視システム

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ グルコース監視システムの北米市場(North America Glucose Monitoring System (Cgms & Smbg) Market Forecast 2017-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆